X

Health Care

ICICI Lombard General Insurance Company Limited (ICICIGI) Q2 FY23 Earnings Concall Transcript

ICICI Lombard General Insurance Company Limited (NSE: ICICIGI) Q2 FY23 Earnings Concall dated Oct. 18, 2022 Corporate Participants: Bhargav Dasgupta…

Everything you need to know about Jubilant Pharmova

About Company and its Outlook:  Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals,…

Jubilant Pharmova reports dip in its net profit by 71% for Q1FY23

Jubilant Pharmova reported total income of INR 1,452 crores during the period ended June 30, 2022 as compared to INR…

Panacea Biotech Q1FY23 Net profit soars by 2%

Panacea Biotec reported total income of INR 111 crores during the period ended June 30, 2022 as compared to INR…

Decoding Panacea Biotec Limited: India’s leading Vaccine Developer

Summary: Universal Immunization Program (UIP) in India is one of the largest public health programs in the world. It targets…

Balaxi Pharmaceuticals Ltd Q1 FY23 Earnings Conference Call Insights

Key highlights from Balaxi Pharmaceuticals Ltd (BALAXI) Q1 FY23 Earnings Concall Q&A Highlights: [00:06:25] Archana Gude with IDBI asked about…

SMS Pharmaceuticals Limited Q1 FY23 Earnings Conference Call Insights

https://youtu.be/G2_d7tTye3s Key highlights from SMS Pharmaceuticals Limited (SMSPHARMA) Q1 FY23 Earnings Concall Q&A Highlights: Atul Kothari from Progwell Securities asked…

Top 5 Stocks with 200% Profit Growth in 2022

1. India Cements Ltd India Cements Ltd is a leading cement manufacturing company based in Chennai. It was founded in…

Gufic Biosciences Limited Q1 FY23 Earnings Conference Call Insights

https://youtu.be/l4VNZKKcWGw Key highlights from Gufic Biosciences Limited (GUFICBIO) Q1 FY23 Earnings Concall Q&A Highlights: Girish Gulati asked about pancreatic cancer…

Aurobindo Pharma Limited Q1 FY23 Earnings Conference Call Insights

https://youtu.be/b8g7f6BUs9Y Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q1 FY23 Earnings Concall Q&A Highlights: [00:08:34] Prakash Agarwal of Axis Capital…